Conference Proceedings
View Meeting Video
Friday, January 23, 2026 | 7:00 am - 4:00 pm
In-person
Hilton Philadelphia City Avenue, 4200 City Avenue, Philadelphia, PA, 19132
AGENDA
Check-in, Breakfast, and Visit Exhibits
Welcome and Introductions
Edward A. Stadtmauer, MD | Activity Director
Robert H. Vonderheide, MD, DPhil | Director, Abramson Cancer Center
SESSION I: NEW THERAPIES AND CURRENT PATIENT MANAGEMENT OF LYMPHOMAS
MODERATOR: Sunita D. Nasta, MD, FACP
Sequencing New Therapies in Follicular Lymphoma
Advances in CLL/SLL
Updates in Management of Hodgkin Lymphoma
Jakub Svoboda, MD | Activity Co-Director
Therapeutic Advances in T-Cell Lymphomas
Novel Approaches to Managing Large B-Cell Lymphomas
Evolving Treatment Strategies in Mantle Cell Lymphoma
Panel Discussion
Break and Visit Exhibits
SESSION II: UPDATE IN BLOOD, MARROW TRANSPLANTATION AND CELLULAR THERAPY
MODERATOR: Nasheed M. Hossain, MD | Activity Co-Director
Equal Access to Transplant: Mismatched Donors for Blood Cancers
Emerging Novel Approaches to Allogeneic HCT
MODERATORS: Nasheed M. Hossain, MD | Activity Co-Director
PANEL:
Nicholas K. Brown, PhD, F(ACHI) | Pathology and Laboratory Medicine
Michael LaRiviere, MD | Radiation Oncology
Shannon R. McCurdy, MD
Pashna N. Munshi, MD
Linda M. Perry, MS, PA-C
Lunch Break and Visit Exhibits
SESSION III: UPDATE ON PATIENT CARE TREATMENT STRATEGIES IN LEUKEMIA
Moderator: Keith W. Pratz, MD | Activity Co-Director
Emerging Treatment Options for AML
MDS Bone Marrow Failure Syndromes
Update in Myeloproliferative Neoplasms
Next Generation of Cellular Therapies
Panel Discussion
MODERATORS: Catherine E. Lai, MD, MPH | Activity Co-Director
PANEL:
Kathryn Allen, CRNP
Daria V. Babushok, MD, PhD
Alison Carulli, PharmD | Oncology Pharmacy
Noelle V. Frey, MD, MS
Elizabeth O. Hexner, MD, MSTR
Keith W. Pratz, MD | Activity Co-Director
Break and Visit Exhibits
SESSION IV: CONTROVERSIES AND UPDATE FOR PATIENT CARE IN MULTIPLE MYELOMA
Moderator: Edward A. Stadtmauer, MD | Activity Director
Smoldering Myeloma and Amyloidosis
Initial Therapy for Multiple Myeloma Including Transplant
Role of Immunotherapy for Myeloma
Edward A. Stadtmauer, MD | Activity Director
Investigational Therapies for Relapsed Myeloma
Panel Discussion
MODERATOR: Edward A. Stadtmauer, MD | Activity Director
PANEL:
Shivani Kapur, MD
Michael LaRiviere, MD | Radiation Oncology
Oxana Megherea, PharmD | Oncology Pharmacy
Leah R. Power, MSN, CRNP
Dan T. Vogl, MD, MSCE
Adam Waxman, MD, MS